Riskpilot← Back to searchSign inGet full accessAPOTEKERGATA 14 AS
ASActiveOrg 979671024Apotekergata 16, 3187 HortenRental and operating of own or leased real estate · NACE 6820Est. 19980 employees
Revenue 2024
NOK 1,6M
+25% vs 2023
EBITDA margin
46.4%
+107% vs 2023
Equity ratio
77.7%
Financial strength
Net profit 2024
NOK 316K
+2211% vs 2023
| Revenue | NOK 1,6M | +25% |
| EBITDA | NOK 756K | +107% |
| Net profit | NOK 316K | +2211% |
| Total assets | NOK 3,9M | -9% |
| Equity | NOK 3M | -5% |
| Employees | 0 | — |
Legal name
APOTEKERGATA 14 AS
Org number
979671024
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
26. februar 1998
Share capital
—
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Å investere i fast eiendom eller selskaper som eier fast eiendom, og alt som dermed står i forbindelse.
Address
Apotekergata 16, 3187 Horten
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 732 | 2 091 | 2 053 | 1 300 | 1 630 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 153 | 1 382 | 842 | 365 | 756 |
| Depreciation & amort. | −300 | −307 | −307 | −324 | −340 |
| EBIT | 853 | 1 076 | 535 | 41 | 416 |
| Net financials | −32 | −7 | −3 | −24 | −11 |
| Profit before tax | 821 | 1 069 | 532 | 18 | 405 |
| Tax | 181 | 235 | 117 | 4 | 89 |
| Net profit | 641 | 833 | 415 | 14 | 316 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 832 | 4 907 | 4 602 | 4 273 | 3 906 |
| Equity | 3 550 | 3 441 | 3 323 | 3 186 | 3 034 |
| Long-term debt | 0 | 0 | 0 | 707 | 181 |
| Short-term debt | 1 282 | 1 466 | 1 280 | 380 | 691 |
| Total debt | 1 282 | 1 466 | 1 280 | 1 088 | 872 |
EBITDA margin
46.4%
This company
15.8%
Market median
+194% vs market
20202024
Equity ratio
77.7%
This company
38.2%
Market median
+103% vs market
20202024
Return on equity
10.4%
This company
18.4%
Market median
+43% vs market
20202024
Net profit margin
19.4%
This company
8.1%
Market median
+140% vs market
20202024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
AK Deputy Member | Deputy Member | 2016 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kwg Holding As
APOTEKERGATA 14 AS Board members of APOTEKERGATA 14 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aase Karine Rød-Larsen | Deputy Member | 0 companies |
| Nicolai Rasch | Chief Executive Officer | 0 companies |
| Georg Bjerch | Board of Directors | 0 companies |
| Kjetil Werner Gulliksen | Board of Directors | 0 companies |
| Tor Rød-Larsen | Board of Directors | 0 companies |
| Carl Christian Krefting | Chairman | 0 companies |